Skin advanced glycation end-products as indicators of the metabolic profile in diabetes mellitus: correlations with glycemic control, liver phenotypes and metabolic biomarkers

Grigorios Christidis,Frederic Küppers,Senem Ceren Karatayli,Ersin Karatayli,Susanne N. Weber,Frank Lammert,Marcin Krawczyk
DOI: https://doi.org/10.1186/s12902-024-01558-9
2024-03-06
BMC Endocrine Disorders
Abstract:The production of advanced glycation end-products (AGEs) is a key pathomechanism related to the complications of diabetes mellitus. The measurement of HbA1c as one of the AGEs is widely used in the clinic, but also other proteins undergo glycation in the course of diabetes. Here, we measure skin AGEs (SAGEs) in patients with diabetes type 1 (DM1) and type 2 (DM2) and correlate them with metabolic markers as well as non-invasively measured liver fibrosis and steatosis.
endocrinology & metabolism
What problem does this paper attempt to address?